How to Keep Mounjaro: Storage and Handling Guide

How to keep Mounjaro safely is an important consideration for anyone using tirzepatide for type 2 diabetes or weight management. Mounjaro (tirzepatide) is a temperature-sensitive peptide medicine supplied as a multi-dose KwikPen in the UK, and incorrect storage can degrade the active ingredient, reducing its effectiveness. This guide covers everything you need to know about storing Mounjaro at home, refrigeration requirements, travelling with your pen, and recognising when a pen may no longer be safe to use, in line with MHRA and UK SmPC guidance.

How to Store Mounjaro Properly at Home

Unopened Mounjaro pens should be refrigerated at 2°C to 8°C in their original carton. Once opened, they can be kept at room temperature not above 30°C for up to 30 days before being discarded.

Mounjaro (tirzepatide) is a peptide medicine that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist used for the management of type 2 diabetes mellitus and weight management. Proper storage is essential to maintain its efficacy. The active ingredient can degrade if exposed to inappropriate temperatures or environmental conditions, potentially reducing the medication's potency.

About the Mounjaro KwikPen: In the UK, Mounjaro is supplied as a multi-dose KwikPen containing four weekly doses per pen. Each pen is for single-patient use only and must never be shared with another person.

Key storage principles for unopened pens include keeping Mounjaro pens in their original carton to protect them from light.^[1][3] Store unopened pens in the refrigerator at temperatures between 2°C and 8°C.^[1][3] Never freeze Mounjaro. If a pen has been frozen, it must be discarded immediately, even if it has subsequently thawed, as freezing can cause irreversible damage to the tirzepatide molecule.

In-use storage (after first use): Once you have used your first dose, the pen can be stored unrefrigerated at temperatures not above 30°C for up to 30 days from the date of first use, after which it must be discarded even if doses remain. Keep the pen in its original carton during this period to protect it from light.

Safe-use reminders:

• Use a new needle for each injection and remove the needle immediately after injecting

• Never store the pen with a needle attached

• Never share your pen with another person

• Check the expiry date before each use and do not use an expired pen

• Store Mounjaro out of reach of children and pets

• Never transfer the solution to another container

Following these storage guidelines helps ensure that each dose delivers the intended therapeutic effect.

Refrigeration Requirements for Mounjaro Pens

Mounjaro pens should be stored on a middle refrigerator shelf at 2°C to 8°C, away from door compartments and cooling elements where temperature fluctuates or freezing may occur.

Refrigeration is the primary storage method recommended for Mounjaro pens. The Medicines and Healthcare products Regulatory Agency (MHRA) and the manufacturer specify that unopened pens should be stored between 2°C and 8°C, the typical temperature range of a domestic refrigerator.^[1] This controlled environment preserves the stability of tirzepatide.

Optimal refrigerator placement matters for maintaining consistent temperature. Store Mounjaro pens in the main body of the refrigerator, ideally on a middle shelf where temperature remains most stable. Avoid placing pens:

• In the door compartments, where temperature fluctuates with frequent opening

• At the back of the fridge near cooling elements, where accidental freezing may occur

• In crisper drawers, which may have different temperature profiles

In-use pens: Once the first dose has been administered, the pen may be kept at room temperature (not above 30°C) for up to 30 days from first use, in line with the UK Summary of Product Characteristics (SmPC). After 30 days from first use, the pen must be discarded regardless of how many doses remain. The SmPC does not recommend returning an in-use pen to the refrigerator once it has been stored at room temperature; follow the instructions in your pen's patient information leaflet for the most up-to-date guidance.

Temperature monitoring is advisable if you have concerns about your refrigerator's performance. Inexpensive fridge thermometers are available from pharmacies and can provide reassurance that your storage conditions remain within the acceptable range. If you experience a power cut, check whether the actual temperature remained within safe limits. If you suspect the pens may have frozen or been exposed to temperatures outside the recommended range, contact your pharmacist or diabetes specialist nurse for advice. If in doubt, obtain replacement medication rather than risk using a potentially compromised pen.

Remember: if a pen has been frozen, even if it has subsequently thawed, it must be discarded.

Travelling with Mounjaro: Storage and Transport Tips

Carry Mounjaro in hand luggage during air travel, use an insulated medical cooling wallet in warm conditions, and bring a GP letter confirming your need for injectable medication and needles.

Travelling with Mounjaro requires advance planning to ensure the medication remains effective throughout your journey. Whether travelling domestically within the UK or internationally, maintaining appropriate storage conditions is essential. Diabetes UK provides guidance for travelling with injectable diabetes medications, which is relevant to Mounjaro users.

For short journeys, an in-use Mounjaro KwikPen kept at room temperature must not exceed 30°C and must be used within 30 days of first use. Keep the pen in its original carton within a protective case to shield it from physical damage and light exposure. During summer months or in warm climates, consider using a medical cooling wallet or insulated medication bag. These products, available from pharmacies and diabetes supply companies, use evaporative cooling or gel packs to maintain a stable temperature. Never place Mounjaro pens directly against ice packs, as this may cause freezing and damage the medication. Do not store the pen with a needle attached during travel.

Air travel considerations include:

• Carrying Mounjaro in hand luggage rather than checked baggage, where temperatures in the hold may fall below freezing^[3]

• Obtaining a letter from your GP or diabetes clinic confirming your need for injectable medication and needles

• Keeping medication in original packaging with pharmacy labels clearly visible

• Having documentation ready to present to security if requested

• Carrying sufficient supplies from the UK, plus extra in case of travel delays, along with spare needles

For longer trips or holidays, you may need to arrange refrigeration at your destination for any unopened pens. Many hotels can provide refrigerator access in rooms or will store medication safely at reception. When booking accommodation, enquire about refrigeration facilities in advance.

International travel requires additional preparation. Carry enough UK-dispensed supply for your entire trip and do not rely on purchasing Mounjaro abroad, as availability and licensing vary by country. Some countries have restrictions on importing medications, so research customs regulations beforehand. Consider travel insurance that covers medication loss or damage, and always carry your prescription or a letter from your healthcare provider detailing your treatment regimen. GOV.UK provides guidance on travelling with medicines and medical sharps that is worth consulting before you travel.

Remember that used Mounjaro pens must be disposed of safely in a sharps container. Discuss with your healthcare provider how to manage sharps disposal while travelling, and check local arrangements at your destination.

Signs Your Mounjaro May No Longer Be Safe to Use

Discard Mounjaro if the solution appears cloudy, discoloured, or contains visible particles, or if the pen has been frozen, physically damaged, or kept at room temperature for more than 30 days.

Recognising when Mounjaro has been compromised is crucial for patient safety and treatment efficacy. Using degraded medication may result in reduced potency and inadequate glycaemic control. Before each injection, perform a visual inspection of the solution through the pen's viewing window.

Mounjaro should appear clear and colourless to slightly yellow. The solution should be free from visible particles, cloudiness, or discolouration. Do not use the pen if you observe:

• Cloudiness or turbidity in the solution

• Visible particles, flakes, or crystals floating in the liquid

• Discolouration, such as brown, pink, or dark yellow tinting

• Any change in the solution's appearance from previous doses

These visual changes indicate that the medication may have degraded, reducing its effectiveness. Even if the pen has been stored correctly, manufacturing defects or damage during transport can occasionally occur.

Physical damage to the pen also warrants disposal. If the pen has been dropped, cracked, or the viewing window is damaged, do not attempt to use it. If the pen mechanism appears faulty, contact your pharmacy for a replacement rather than forcing the device.

Storage-related concerns that necessitate disposal include:

• Confirmed or suspected freezing of the medication

• Exposure to temperatures above 30°C

• In-use pens that have been at room temperature for longer than 30 days from first use

• Pens with missing or damaged labels making it impossible to verify expiry dates

• Any pen that has passed its printed expiry date

If you are uncertain about your Mounjaro's safety, contact your community pharmacist or diabetes specialist nurse for guidance. They can assess whether the medication should be replaced and advise on obtaining a new prescription if needed.

Dispose of used Mounjaro pens in a proper sharps container. Sharps disposal arrangements vary locally: check with your pharmacy, GP practice, or local council for clinical waste collection services in your area. Proper disposal protects others from accidental needle-stick injuries and prevents environmental contamination.

If you experience any suspected side effects from Mounjaro, report them to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Scientific References

1. Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC).
2. Mounjaro (tirzepatide) - European Public Assessment Report (EPAR).
3. Mounjaro KwikPen - Instructions for Use.
4. Tirzepatide for managing overweight and obesity. Technology appraisal guidance [TA1026].
5. Type 2 diabetes in adults: management. NICE guideline [NG28].

Frequently Asked Questions